Manufacturers Life Insurance Company, The Myriad Genetics Inc Transaction History

Manufacturers Life Insurance Company, The

  • $103 Billion
  • Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Myriad Genetics Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 45,543 shares of MYGN stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,543
Previous 41,117 10.76%
Holding current value
$1.13 Million
Previous $786,000 23.41%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.59 - $23.59 $77,853 - $104,409
4,426 Added 10.76%
45,543 $970,000
Q4 2023

Feb 13, 2024
BUY
$13.91 - $21.32 $1,752 - $2,686
126 Added 0.31%
41,117 $786,000
Q3 2023

Nov 15, 2023
BUY
$15.99 - $23.22 $133,900 - $194,444
8,374 Added 25.67%
40,991 $657,000
Q2 2023

Aug 11, 2023
BUY
$17.56 - $23.76 $12,116 - $16,394
690 Added 2.16%
32,617 $756,000
Q1 2023

May 15, 2023
BUY
$15.26 - $23.75 $2,044 - $3,182
134 Added 0.42%
32,061 $744,000
Q4 2022

Aug 11, 2023
BUY
$14.51 - $20.99 $2,495 - $3,610
172 Added 0.54%
31,927 $463,000
Q4 2022

Feb 13, 2023
BUY
$14.51 - $20.99 $2,495 - $3,610
172 Added 0.54%
31,927 $463,000
Q3 2022

Aug 11, 2023
SELL
$18.21 - $27.88 $11,982 - $18,345
-658 Reduced 2.03%
31,755 $605,000
Q3 2022

Nov 03, 2022
SELL
$18.21 - $27.88 $11,982 - $18,345
-658 Reduced 2.03%
31,755 $606,000
Q2 2022

Aug 11, 2023
SELL
$16.45 - $25.88 $7,978 - $12,551
-485 Reduced 1.47%
32,413 $588,000
Q2 2022

Aug 15, 2022
SELL
$16.45 - $25.88 $7,978 - $12,551
-485 Reduced 1.47%
32,413 $589,000
Q1 2022

Aug 11, 2023
BUY
$22.67 - $28.01 $18,974 - $23,444
837 Added 2.61%
32,898 $829,000
Q1 2022

May 20, 2022
SELL
$22.67 - $28.01 $162,770 - $201,111
-7,180 Reduced 17.92%
32,898 $829,000
Q4 2021

Feb 16, 2022
SELL
$24.13 - $32.63 $3,016 - $4,078
-125 Reduced 0.31%
40,078 $1.11 Million
Q3 2021

Nov 12, 2021
SELL
$29.97 - $36.66 $90,988 - $111,299
-3,036 Reduced 7.02%
40,203 $1.3 Million
Q2 2021

Aug 12, 2021
BUY
$25.39 - $32.61 $75,941 - $97,536
2,991 Added 7.43%
43,239 $1.32 Million
Q1 2021

May 03, 2021
SELL
$19.92 - $31.6 $56,612 - $89,807
-2,842 Reduced 6.6%
40,248 $1.23 Million
Q4 2020

Feb 12, 2021
BUY
$12.16 - $19.77 $14,129 - $22,972
1,162 Added 2.77%
43,090 $852,000
Q3 2020

Nov 09, 2020
SELL
$11.25 - $14.75 $9,663 - $12,670
-859 Reduced 2.01%
41,928 $547,000
Q2 2020

Aug 10, 2020
SELL
$10.69 - $16.49 $26,008 - $40,120
-2,433 Reduced 5.38%
42,787 $472,000
Q1 2020

May 15, 2020
BUY
$9.78 - $29.53 $31,442 - $94,938
3,215 Added 7.65%
45,220 $647,000
Q4 2019

Feb 14, 2020
SELL
$20.93 - $35.1 $25,367 - $42,541
-1,212 Reduced 2.8%
42,005 $1.14 Million
Q3 2019

Nov 12, 2019
SELL
$22.08 - $47.08 $10,377 - $22,127
-470 Reduced 1.08%
43,217 $1.23 Million
Q2 2019

Aug 14, 2019
SELL
$22.67 - $35.0 $28,201 - $43,540
-1,244 Reduced 2.77%
43,687 $1.21 Million
Q1 2019

May 13, 2019
BUY
$26.93 - $34.7 $93,097 - $119,957
3,457 Added 8.34%
44,931 $1.49 Million
Q4 2018

Feb 14, 2019
SELL
$27.23 - $45.56 $42,043 - $70,344
-1,544 Reduced 3.59%
41,474 $1.21 Million
Q3 2018

Nov 14, 2018
SELL
$37.57 - $50.34 $201,713 - $270,275
-5,369 Reduced 11.1%
43,018 $1.98 Million
Q2 2018

Aug 14, 2018
SELL
$27.75 - $40.17 $83 - $120
-3 Reduced 0.01%
48,387 $1.81 Million
Q1 2018

May 15, 2018
SELL
$28.83 - $41.01 $32,376 - $46,054
-1,123 Reduced 2.27%
48,390 $1.43 Million
Q4 2017

Feb 08, 2018
BUY
$28.45 - $37.14 $23,670 - $30,900
832 Added 1.71%
49,513 $1.7 Million
Q3 2017

Nov 14, 2017
BUY
$24.01 - $36.2 $1.17 Million - $1.76 Million
48,681
48,681 $1.76 Million

Others Institutions Holding MYGN

# of Institutions
191
Shares Held
94.2M
Call Options Held
280K
Put Options Held
14.3K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email